These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33821283)

  • 1. COVID-19 vaccine impact on rates of SARS-CoV-2 cases and post vaccination strain sequences among healthcare workers at an urban academic medical center: a prospective cohort study.
    Bouton TC; Lodi S; Turcinovic J; Weber SE; Quinn E; Korn C; Steiner J; Schechter-Perkins EM; Duffy E; Ragan EJ; Taylor BP; Schaeffer B; Miller N; Davidoff R; Hanage WP; Connor J; Pierre C; Jacobson KR
    medRxiv; 2021 Apr; ():. PubMed ID: 33821283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus Disease 2019 Vaccine Impact on Rates of Severe Acute Respiratory Syndrome Coronavirus 2 Cases and Postvaccination Strain Sequences Among Health Care Workers at an Urban Academic Medical Center: A Prospective Cohort Study.
    Bouton TC; Lodi S; Turcinovic J; Schaeffer B; Weber SE; Quinn E; Korn C; Steiner J; Schechter-Perkins EM; Duffy E; Ragan EJ; Taylor BP; Miller N; Davidoff R; Hanage WP; Connor J; Pierre C; Jacobson KR
    Open Forum Infect Dis; 2021 Oct; 8(10):ofab465. PubMed ID: 34646910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine.
    Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A
    BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response.
    Ontañón J; Blas J; de Cabo C; Santos C; Ruiz-Escribano E; García A; Marín L; Sáez L; Beato JL; Rada R; Navarro L; Sainz de Baranda C; Solera J
    EBioMedicine; 2021 Nov; 73():103656. PubMed ID: 34740112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy.
    Milazzo L; Pezzati L; Oreni L; Kullmann C; Lai A; Gabrieli A; Bestetti G; Beschi C; Conti F; Ottomano C; Gervasoni C; Meroni L; Galli M; Antinori S; Ridolfo AL
    Hum Vaccin Immunother; 2021 Dec; 17(12):4747-4754. PubMed ID: 35086438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of mRNA vaccines in curtailing SARS-CoV-2 infection and disability leave utilisation among healthcare workers during the COVID-19 pandemic: cross-sectional analysis from a tertiary healthcare system in the Greater Houston metropolitan area.
    Vahidy FS; Pan AP; Hagan K; Bako AT; Sostman HD; Schwartz RL; Phillips R; Boom ML
    BMJ Open; 2021 Oct; 11(10):e054332. PubMed ID: 34642201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers.
    Trunfio M; Verga F; Ghisetti V; Burdino E; Emanuele T; Bonora S; Di Perri G; Calcagno A
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urban-rural divide in COVID-19 infection and vaccination rates in healthcare workers in British Columbia, Canada.
    Yassi A; Barker S; Lockhart K; Taylor D; Harris D; Hundal H; Grant JM; Okpan AI; Pollock S; Sprague S; Sing CK
    Can J Rural Med; 2023; 28(2):47-58. PubMed ID: 37005988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
    Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
    Int J Infect Dis; 2021 Dec; 113():15-17. PubMed ID: 34614445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
    Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
    JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA Vaccination.
    Dieckhaus KD; Kim MJ; Shen JB; Liang TS; Kleinberg MJ; Siedlarz KM; Banach DB; Metersky ML; Fuller RP; Mortensen EM; Liang BT
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
    Alishaq M; Nafady-Hego H; Jeremijenko A; Al Ajmi JA; Elgendy M; Vinoy S; Fareh SB; Veronica Plaatjies J; Nooh M; Alanzi N; Kaleeckal AH; Latif AN; Coyle P; Elgendy H; Abou-Samra AB; Butt AA
    PLoS One; 2021; 16(10):e0258820. PubMed ID: 34653228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.